Sign In
Buy EVH
$5.92
+0.0400 (+0.680%)
At Close: Jul 13, 2026
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
04:30pm, Wednesday, 08'th Jul 2026
WASHINGTON, July 8, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its
Should You Buy Evolent Health (EVH) After Golden Cross?
10:56am, Friday, 03'rd Jul 2026
Evolent Health, Inc (EVH) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, EVH's 50-day simple moving average crossed above it
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?
11:56am, Monday, 29'th Jun 2026
Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more stren
Agentic AI Powers U.S. Healthcare Stocks
08:19pm, Sunday, 17'th May 2026
Healthcare payrolls keep climbing, and hospital systems, payers, and clinics are now openly treating agentic AI as the cheapest unit of labor on the market.
Evolent Health Q1 Earnings Call Highlights
05:13am, Sunday, 10'th May 2026
Evolent Health NYSE: EVH reported first-quarter 2026 results that management said were in line with expectations, while reiterating its full-year outlook and highlighting new contract wins, early prog
Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript
05:31pm, Friday, 08'th May 2026
Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript
Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics
10:31am, Thursday, 07'th May 2026
While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics com
Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates
09:56am, Thursday, 07'th May 2026
Evolent Health (EVH) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to earnings of $0.06 per share a year ago.
Evolent Announces First Quarter 2026 Results
07:00am, Thursday, 07'th May 2026
WASHINGTON, May 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through p
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
04:30pm, Tuesday, 07'th Apr 2026
WASHINGTON, April 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release it
Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of “Moderate Buy” by Brokerages
02:47am, Saturday, 21'st Mar 2026
Evolent Health, Inc (NYSE: EVH - Get Free Report) has earned an average rating of "Moderate Buy" from the seventeen analysts that are covering the firm, MarketBeat Ratings reports. One investment anal
Evolent announces appointment of Archie Mayani as chief product officer
08:45am, Thursday, 19'th Mar 2026
Industry veteran brings track record of innovation from GHX, Change Healthcare, UnitedHealth Group and Amazon. WASHINGTON, March 19, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company fo
8 Knots Management LLC Lowers Position in Evolent Health, Inc $EVH
03:23am, Sunday, 15'th Mar 2026
8 Knots Management LLC trimmed its holdings in shares of Evolent Health, Inc (NYSE: EVH) by 39.3% in the undefined quarter, according to the company in its most recent disclosure with the Securities a
Evolent to Participate in Upcoming Investor Conferences
05:00pm, Thursday, 26'th Feb 2026
WASHINGTON, Feb. 26, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced that members of it
Evolent Health: Cheap, Levered, But Ready To Rebound
10:38am, Thursday, 26'th Feb 2026
Evolent Health, Inc. is rated a Buy, with turnaround momentum and risk/reward now favoring upside after recent operational and strategic shifts. EVH's Performance Suite model now covers ~90% of revenu
